Company Description

Theralytix develop broad spectrum bacteriophage products that deploy bacteriophages active against multiple strains of pathogenic bacteria in the following genera: Salmonella, Shigella, Pseudomonas, Escherichia, Staphylococcus, Streptococcus, Enterococcus, Proteus, Klebsiella and Acinetobacter.